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The  importance of  the  serum  lipids  and  of  their  interrelationships  in  the 
genesis of atherosclerosis has been repeatedly emphasized.  In young patients 
with myocardial infarction (1, 2) and in those diseases that are associated with 
hyperlipemia and  excessive  atherosclerosis,  such  as  diabetes  mellitus,  hypo- 
thyroidism  and  hypercholesterolemic  xanthomatosis,  hypercholesterolemia, 
and a decreased phospholipid to cholesterol ratio have been observed frequently. 
Experimentally, the expected development of atherosclerosis  in rabbits fed choles- 
terol has been inhibited by rendering them diabetic with alloxnn  (3-5). The failure 
to develop atherosderosis occurred  in the presence of marked elevations of the con- 
tent of cholesterol  in the serum together with a proportionate elevation of the serum 
phospholipids and neutral fat. A similar increase in serum cholesterol and phospholip- 
ids has been obtained by the  intravenous injection of the detergents tween 80 and 
triton A 20 into cholesterol-fed  rabbits (6-8); there was an inhibition of the expected 
development of atherosderosis. 
Many clinical observations and experimental studies  have revealed that cortisone 
produces well defined  changes  in  the serum lipids.  In the sera of patients receiving 
prolonged cortisone therapy, Adlersberg  and his  associates  (9-12)  noted  that  there 
was a  consistent elevation of the total serum  cholesterol,  esterified  cholesterol,  and 
phospholipids.  In view of his findings and the common association  of hypereholester- 
olemia with atherosderosis, Adlersberg  suggested  that atherosderosis  might develop 
prematurely in patients  treated with cortisone.  Indeed,  Etheridge and Hoch-Ligeti 
(13)  have reported  an  increase  in  the  severity of atheroderosis  in young patients 
treated with cortisone. 
Kobernick and More (14), while  studying the effect of cortisone  on tissue lesions 
produced by foreign  serum proteins in rabbits, observed changes  in the blood sugar 
and serum lipids  that resembled those of alloxan  diabetes and were accompanied by 
glycogen  infiltration  of the  islets  of Langerhans.  They reported an increase  in  the 
serum lipid phosphorus, total and free cholesterol, and fatty acids of neutral fat which 
presented a pattern similar to that described  by Payne and Duff (5) in the alloxan 
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diabetic rabbit.  Since alloxan diabetes inhibits the development of cholesterol athero- 
sclerosis in the rabbit, it seemed appropriate to consider whether cortisone might also 
inhibit the development of experimental cholesterol atherosclerosis. Meanwhile, Cook, 
Roger, Davison, Feldstein, Calvin, and Green (15) have reported that cortisone does 
not affect the development of atherosclerosis in the rabbit fed cholesterol, but Oppen- 
helm and Bruger (16) found that cortisone has an inhibitory  action  on  the develop- 
ment of lesions in such animals. 
The following experimental study provides further  data on the effect of the 
administration  of cortisone on the serum lipids and the development of experi- 
mental  cholesterol atherosclerosis  in  the  rabbit. 
EXPERIMENTAL 
Materials and Methods 
Experimental Anlmals.--Seventy-two New Zealand white rabbits of pedigreed stock were 
employed. These comprised 9 sets of quadruplets and 12 sets of triplets. Each individual set 
Of litter mates was of the same sex; both sexes were about equally represented in the experi- 
ment. The rabbits varied in age from 10 to 16 weeks and weighed from 1,640 to 3,650 gin. at 
the beginning of the experiment. The majority of them weighed from 2,200 to 2,800 gin. 
The 9  sets of quadruplets were divided into four groups that received respectively: (1) 
cholesterol and cortisone vehicle; (2)  cholesterol and cortisone;  (3)  cortisone; (4)  cortisone 
vehicle. One of the quadruplets was compared with a litter mate of the same sex in each of 
the other experimental groups.  The triplets were grouped in a  corresponding  manner,  but 
the group 4 rabbits that received only cortisone vehicle were not represented. 
Experimental Treatment.--The duration of the experiment was about 2 months. Cholesterol 
was administered by coating 35 gin. of commercial rabbit food pellets with 0.75 gm. of choles- 
terol dissolved in ether.  The ether was allowed to evaporate leaving a  film of cholesterol 
adherent to the food. This amount of cholesterolized food was given daily in the morning to 
each rabbit of groups 1 and 2 for 6 days each week. When this ration was  consumed it was 
supplemented each afternoon with 65 gm. of food that did not contain cholesterol. 100  gin. 
of food pellets without added cholesterol was given daily to those rabbits  that were not  to 
receive cholesterol and to all rabbits on the 7th day of each week. The cholesterol consumption 
was measured daily by weighing any uneaten portion of the cholesterolized food ration of each 
animal. 
Cortisone or cortisone vehicle was injected intramuscularly from a tuberculin syringe. The 
animals of groups 2 and 3 received daily 3 mR. of cortisone per kilo of body weight for the 
first 3 weeks of the experiment, 2 mR./kilo for the succeeding 3 days, 1.5 mR./kilo for 3 days, 
0.5 mg./kilo for 11 days, 1.0 mg./kilo for 2 days, and 1.5 reg./kilo for the terminal period of 
up to 3 weeks. These variations in dosage were dictated by the general state of the surviving 
animals. 3 rag. of cortisone per kilo of body weight was not well tolerated by the rabbits after 
some 3 weeks of treatment and several rabbits died. Indeed, if the dose of cortisone had not 
been reduced there would have been no surviving rabbits within a short period of time. 
Metabolic Observations.--All rabbits were weighed each week. Determinations of the blood 
sugar (17) were made weekly on all rabbits. Samples of blood for chemical estimations of the 
serum-free and total cholesterol (18), lipid phosphorus (19), and serum total fatty acids (20) 
were taken on all rabbits every 2 weeks. Fatty acids of serum neutral fat were calculated from 
these data (21). Extracts of sera were stored for subsequent analysis since this was not feasible 
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Assessment of A theroselerosis.--Surviving litter mates were sacrificed  and all animals were 
autopsied. The aorta was removed, opened and the severity  of atherosclerofic  involvement  was 
graded as normal or grade 0; trace; slight or grade +; and moderate or grade ++.  The size 
and distribution of the lesions were then recorded on semischematic diagrams. The adventitia 
of the fresh, unfixed aorta was dissected from the media and intima and discarded. The re- 
maining aortic media and intima of each individual animal were extracted with hot ethyl 
alcohol in a  continuous extraction apparatus for 6 hours and were subsequently extracted 
with ethyl ether at room temperature for 18 hours. The alcohol and ether extracts were com- 
bined. An aliquot of the extract was evaporated almost to dryness, redissolved in acetone- 
alcohol, and its cholesterol content was determined by the same method used to determine 
the serum cholesterol. The results were expressed as milligrams of cholesterol content per 
aorta. 
RESULTS 
Experimental Mortality.--The mortality among the rabbits of groups 2 and 
3 receiving cortisone was severe. 14 of 21 rabbits receiving only cortisone died: 
deaths occurred on days 13, 24, 26, 26, 39, 40, 41, 45, 49, 54, 55, 55, 57, and 57 
after the  beginning  of the  experiment.  13  of 21  cholesterol-fed rabbits  that 
also received cortisone died: deaths occurred on days 21,  24,  24,  24,  25,  29, 
29, 29, 41, 44, 46, 55, and 57 of the experiment. 2 of 21 rabbits of group 1 that 
received cholesterol and cortisone vehicle died on days 22 and 55 respectively. 
None of the 9 rabbits of group 4 that received only cortisone vehicle died. 
Because of the experimental mortality, only certain animals  could be use- 
fully considered. These were 7  sets of quadruplets,  4  sets of triplets,  and  1 
pair of twins. Thus, the experimental data reported below were derived from 
12 rabbits that were fed cholesterol, 12 of their litter mates fed cholesterol and 
treated with cortisone, 11 of their litter mates  treated with cortisone, and  7 
of their litter mates that received cortisone vehicle only. These animals  com- 
prised all those that died on or after the 44th day of the experiment together 
with the litter mates that were with them. 
Sugar Content of the Blood.--Blood sugar levels determined weekly through- 
out the experiment varied only slightly. The mean of the values for either group 
1 or group 4 at any one time was not less than 101 nor more than 123 rag. per 
cent. The cortisone-treated groups, however, possessed mean levels of approxi- 
mately 140 to 160 rag. per cent while being treated daily with 1.5 to 3.0 rag. 
of cortisone per kilo of body weight. When the cortisone dosage was less than 
1.5 rag. per kilo the mean blood sugar values of groups 2 and 3 were within 
normal limits. On only a  few occasions was the content of sugar in the blood 
observed to exceed 200 mg. per cent in individual rabbits. The highest value 
detected was 398 rag. per cent. 
Severity  of Cholesterol Atherosderosis.--The  detailed data derived from the 
12 rabbits fed cholesterol and their 12 litter mates that received both cholesterol 
and cortisone are summarized in Table I in which pairs of rabbits are compared. 
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TABLE  I 
Effect of Cortisone on Serum Lipids and  Aortic Atherosclerosis  in Litter Mate 
Rabbits  Fed  Cholesterol 
Rabbit 
No. 
Change 
initial 
• 
weight 
days  &m.  rag.  gin.  gin.  per cen| 
V-71  F  44  27  --  2293 2717 +18.5 
V-72  F  44  23  230  281C 2345 -16.5 
V-97  M  45  28  --  2167 2798 +29.1 
V-98  M  45  27  189  2445  2720 +11.2 
W-5  M  46  27  --  2042 2595 +27.1 
W-6  M  46  28  186  2205 2460 +11.6 
W-1  F  49  30  '  --  .1884 2572 !  +36.5 
W-2  F  49  30  259  2751 2475  --10.0 
W-9  F  54  33  --  2310 3035  +31.4 
W-10 1 F  54  30  210  2420 2482  +2.6 
%84]  M  55  32  --  2935 3191  +8.7 
V-85  M  55  32  249  2545240£  -5.7 
V-67  M  55  32'--'2968297~  +0.2 
V-68 ] M  55  34  304  2810269C  --4.3 
V-52 ] M  55  31  --  2159 1779 --17.6 
V-53  M  56  31  313  2852 2627  --7.9 
V-88  M  57  34  --  2860344£ +20.3 
V-89 [ M  57  27  219  2450 1985 --19.0 
V-64  M  57  35  --  3368372C  +10.5 
V-65  M  57  30  267  2690 2248--16.4 
V-77  F  60  35  .  --  .260~ 2955 +13.7 
V-79  F  60  37  246  2315 2540  +9.7 
W-29  F  61  32  --  3650 3455  --5.3 
W-30  F  60  27  278  2888 2435--15.7 
Average serum lipid content  Cho- 
|es. 
Grtde of  terol 
Fatty  aortic  Cholesterol  a~° .~  acids  athero-  con- 
~  of  sclerosia  tent  -~ o  of  •  B.~  neutral 
Free  Total  Ester  ~  ~  fat  aorta 
rag.  rag.  m.ef./ 
per  per  rag.  cmt  c~  liter 
1.7.~ 
0.8~ 
183.2  8.0  4.18  1.25 
257.2 11.6  21.62  0.65 
591.518.4  8.59  4.75 
209.8 13.3  21.93  1.50 
124.6  7.1  5.74  1.38 
136.2  8.5[  19.97  1.20 
276.6 10.21  3.11  1.43 
146.0 12.2  27.43  0.63 
145.8  6.8 ]  2.48  0.65 
91.8 12.8  18.05  0.85 
300.0 11.7  3.10  1.75 
91.4 12.3!  46.77  0.58 
13.3]  7.29  2.05  300.5 
122.1 12.0  37.05  0.75 
i 
294.0  6.6  0.73  2.28 
91.0  9.0  25.36  1.13 
580.3 14.5  2.56  2.88 
144.8  7.2  18.96  0.95 
113.6  6.9  2.68  0.95 
78.6 10.7  29.77 
353.2 12.4  8.82  2.5~ 
54.5  6.9  11.64  1.25 
than  their control  litter mates,  but  this  difference  was  usually  slight.  On  the 
average the rabbits of group 1 each ate a  total of 31.3 gm. of cholesterol while D. GORDON~  S. D. KOBERNICK~  G. C. McMILLAN~  G. L. DUFF  375 
those of group  2 ate 29.6 gin.  In II of the pairs of animals the severity of aortic 
atherosderosis was judged by visual inspection to be less in the cortisone-treated 
rabbits; neither of the 12th pair Of animals had macroscopically visible athero- 
sclerotic lesions. In 9 pairs of rabbits the cholesterol content of the aorta was 
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FIO. 1. Graph of serum-free cholesterol  plotted against days of experimental treatment. 
Line I  was derived from rabbits fed cholesterol, line II from rabbits fed cholesterol and 
treated with cortisone, III from rabbits treated with cortisone,  and IV from normal control 
animals. 
definitely less by chemical determination in the cortisone-treated litter mates; 
in 2 pairs the content was about the same; in the remaining pair one of the 
samples  was  lost.  In all  cases the  amount  of atherosclerosis that  developed 
was small.  The mean aortic cholesterol content of the group  1 animals  that 
received cholesterol and  cortisone vehicle was  1.97  rag.;  that  of the rabbits 
receiving both cortisone and cholesterol was 0.94 rag. The probability of this 
difference is about 0.01. 376  EPFECT  O~  CORTISObTE  ON  ATHEROSCLEROSIS 
Variations in Body Weight.~There was  a  considerable  variation in  body 
weight among the various animals at the beginning of the experiment. This 
was true not only of unrelated rabbits but also of litter mates. The average 
initial weights of the rabbits of groups 1 and 2 were 2,503 and 2,598 gin. re- 
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l~o. 2.  Graph of serum total cholesterol plotted against days of experimental treatment. 
Line I was derived from rabbits fed cholesterol, line II from rabbits fed cholesterol  and treated 
with cortisone, III from rabbits treated with cortisone, and IV from normal control animals. 
spectively. During the course of the experiment most of the rabbits of group 1 
gained weight while those of group 2 lost weight. The mean final weight of the 
group 1 rabbits was 2,936 gm., that of the group 2 animals was 2,461  gln. The 
probability of  this  difference  is  about  0.02.  There were  some  exceptions  to 
these findings:  rabbits W-5  and W-6,  and V-97  and V-98  all  gained weight 
although  the  cortisone-treated  rabbits  did  not  gain  as  much  as  their  litter 
mates; contrarily, rabbits V-52 and V-53 both lost weight, the cortisone-treated 
rabbit losing less weight than its litter mate which did not thrive. D.  GORDON,  S.  D.  KOBERNICK,  G.  C.  ~[cMILLAN,  G.  L.  DUFF  377 
Variations in the Content  of Lipids in the Serum.--The average contents of 
lipids in the serum of the individual rabbits of groups 1 and 2 that survived 
the entire experiment from day 4  to its termination have been tabulated in 
Table I. It should be noted that the content of lipids in the serum of the sur- 
viving animals, in particular those of groups 2 and 3 which were treated with 
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FIG. 3.  Graph of serum-esterifled cholesterol plotted against days of experimental treat- 
merit. Line I  was derived from rabbits fed cholesterol, line II from rabbits fed cholesterol and 
treated with cortisone, III from rabbits treated with cortisone, and IV from normal control 
animals. 
cortisone and suffered a  heavy mortality, did not differ materially from the 
serum lipid content observed at the same times in the animals that died during 
the experiment. Among the survivors it was observed that in 8  of the pairs 
of rabbits the litter mate treated with cortisone had considerably lower serum 
cholesterol levels, in 2 pairs the difference was slight, in 1 pair the cortisone- 
treated rabbit had an appreciably higher content of cholesterol in the serum. 
The analyses on one pair were too few to be included as averages in Table I. 378  ]g]~lrEC~  O~  COI~TISON~  ON  ATJ:~I~OSCLEROSIS 
It was  the  esterifled cholesterol fraction that  showed the  greater difference 
while the free cholesterol fraction did not differ so much. The serum total fatty 
acids and fatty acids of neutral fat of the cortisone-treated rabbits were always 
greatly increased over those of their group 1 litter mates.  The average lipid 
6 
u~ 
0 
-l- 
a. 
o~ 
0 
"I" 
0. 
E 
.J 
16 
12 
10 
•  lU 
/ 
/ 
..\ 
/-  ... / 
•  ee eee°  ~ 
I!  /" 
...'/ 
-/ 
\ 
IV 
OAYS 
Fro. 4.  Graph of serum lipid phosphorus plotted against days of experimental treatment. 
Line I was derived  from rabbits fed cholesterol,  line H from rabbits fed cholesterol  and treated 
with cortisone, III from rabbits treated with cortisone, and IV from normal control animals. 
phosphorus content of the serum, while variably elevated, was essentially the 
same for the two groups of rabbits. 
The experimental differences in the serum lipids are shown in greater detail 
in Figs. 1 to 5 in which the mean quantities of serum lipids for groups 1, 2, 3, 
and 4 are plotted at biweekly intervals during the course of the experiment. 
The results are noteworthy not only for the differences that are shown, but for 
their constancy. The di~erences noted in Table I  between groups 1 and 2 are 
observed throughout the course of the experiment. It is seen that the rabbits D. GORDON,  S. D. KOBERNICK,  G. C. MCMqJ.LAN~  G. L. DUFF  379 
of group 3 that received only cortisone attained a  content of neutral fat in the 
serum as great as that found in their litter mates of group 2 that received both 
cortisone and cholesterol. Moreover,  they had amounts of lipid phosphorus  in 
the serum as great as those of the rabbits that received  both cortisone  and 
cholesterol  or that had only cholesterol.  In addition, the content of serum 
60 
I- 
a.  50 
.J 
~t 
tr 
1- 
40. 
tU 
U. 
0 
30' 
20' 
I- 
I-- 
/  lU 
I 
I 
I 
I 
/.:~,,~  /  •  u  //."  ""?..x  /  "" 
-"  "... ~/  ..." 
/  ..  ...  .-" 
/"  "../  I/  ""  ""  // 
// 
// 
10  /"" 
o  4  f4  ~a  4z ....  g,s' 
DAYS 
FIG.  5.  Graph of serum fatty acids of neutral fat plotted against days of experimental 
treatment. Line I was derived from rabbits fed cholesterol, line II from rabbits fed cholestero 
and treated with cortisone, III from rabbits treated with cortisone, and IV from normal con- 
fro] animals. 
cholesterol,  especially free cholesterol in the rabbits of group 3 gradually in- 
creased during the course of treatment with cortisone. 
The ratio of the serum total cholesterol  to the lipid  phosphorus  was ele- 
vated 2 to 4 times in the cholesterol-fed rabbits of group 1. It was increased 
by about  1.5  to 2  times in  the  cortisone-treated cholesterol-fed  animals of 
group 2 and remained within normal limits in the rabbits of group 3 that re- 
ceived cortisone only. 
DISCUSSION 
The effect on the serum lipids of the repeated daily administration of moder- 
ate and large  doses  of cortisone  to normal and cholesterol-fed  rabbits  was 380  EFFECT OF CORTISONE ON ATe[EROSCLEROSIS 
definite and consistent both in the rabbits that died early in the experiment 
because of cortisone overdosage and in those that survived because of a reduc- 
tion in the amount of cortisone administered. 
There occurred a  moderate elevation of  the free and esterified cholesterol 
fractions in the normal rabbit treated with cortisone. The free cholesterol was 
elevated relatively more  than  the  esterified fraction.  In  the  cholesterol-fed 
rabbit the expected elevation of the serum cholesterol attributable to the cho- 
lesterol feeding was  decreased by cortisone treatment  until  the  free  choles- 
terol was only about 70 per cent of the expected value and  the  ester  fraction 
was only 40 per cent of the expected amount. 
The  influence  of  cortisone  on  cholesterol metabolism  presents  a  curious 
paradox. On the one hand it promoted a  hypercholesterolemia in which the 
cholesterol was of endogenous origin; on the other hand it depressed the ex- 
pected development of hypercholesterolemia due to exogenous cholesterol. In 
the former case it elevated the free cholesterol relatively more than the ester; 
in the latter case it depressed the free cholesterol less than the ester. It was 
apparent that the unesterified cholesterol was more labile than the esterified 
fraction was.  There is  no ready explanation of these  apparently anomalous 
effects. Elevation of the serum cholesterol in normal animals can be caused by 
agents such as tween 80 or triton A 20 or the diabetic state caused by alloxan 
(3-8), but they do not depress the hypercholesterolemia resulting from cho- 
lesterol feeding. Similarly, treatment with thyroid hormone or iodides (22-25) 
will reduce the hypercholesterolemia of cholesterol feeding but it will not ele- 
vate the serum cholesterol of normal rabbits that are not fed cholesterol. The 
effect of cortisone on the serum cholesterol is singular and its mechanism or 
mediation remains obscure. 
Cortisone caused a  moderate elevation of the serum lipid phosphorus.  In 
normal rabbits this elevation was sufficient to maintain a normal total choles- 
terol/lipid phosphorus  ratio.  When  the  rabbits  received either  0.75  gin.  of 
cholesterol or both cortisone and cholesterol daily, the serum lipid phosphorus 
levels were also elevated to almost exactly the same amount as that in the 
rabbits receiving only cortisone. In the present experiment therefore, the ad- 
ministration of cortisone duplicated the effect of cholesterol feeding, but cho- 
lesterol and cortisone together did not have a  cumulative effect. This latter 
fact cannot be explained by the assumption that the serum phospholipids had 
attained  the maximum possible  levels since, in  our experience, much larger 
amounts have been found in the serum of rabbits injected with tween 80 (8) 
or rendered diabetic with aUoxan and fed cholesterol (5). It is of interest to 
note that  there is evidence that cholesterol feeding and the alloxan-diabetic 
state, each of which is capable of causing a  moderate elevation in the serum 
lipid phosphorus levels, may have a  cumulative effect when combined.  This 
evidence, while very strong,  is  not  absolute  because  a  small  percentage of D. GORDON,  S. D.  KOBF.RNICK,  G. C. MCM~LLAN,  G. L. DUFF  381 
diabetic rabbits will have serum lipid phosphorus levels as high as  those of 
cholesterol-fed, diabetic animals (26). The coincidence of the lipid phosphorus 
levels in the rabbits of groups 1, 2, and 3 is probably fortuitous: it is presumed 
that a  larger dose of cholesterol together with vegetable oil would  have in- 
creased the serum phospholipids of groups 1 and 2. Whether they would have 
increased by equal amounts can only be conjectured. 
Inasmuch as  the  average  levels  of  total  cholesterolemia attained by  the 
animals of groups 1, 2, and 3 were different while levels of phospholipidemia 
were  the  same,  the  total  cholesterol/phospholipid ratios  varied  among  the 
three groups. It was normal in the animals receiving only cortisone, increased 
in those receiving both cholesterol and cortisone, and grossly increased in the 
rabbits that received only cholesterol. 
The content of triglyceride in the serum of the cholesterol-fed rabbits  in- 
creased approximately two times: that of the cortisone-treated rabbits and of 
the cholesterol-fed, cortisone-treated rabbits was increased 8 to 10 times. The 
data do not indicate  whether cortisone  treatment together with cholesterol 
feeding had a  cumulative effect on the  serum neutral fat or not.  On the con- 
trary, the results show that the animals of group 2  had somewhat less serum- 
neutral fat than those of group 3, but the data are meager and are not an ade- 
quate basis for speculation.  The great elevation in the serum triglycerides of 
the cortisone-treated rabbits  is reminiscent of that seen in alloxan  diabetes 
with or without cholesterol feeding. It does not occur with the  intravenous 
injection of tween 80. 
Oppenheim and Bruger  (16)  have reported  an  experiment  similar to  the 
present one. However, the results of their analyses of the serum lipids were 
not the same as ours. They gave 5 normal rabbits  10 rag. of cortisone three 
times weekly for 10 weeks, There was no significant effect on the serum cho- 
lesterol but there was a  definite increase in the serum phospholipids. 13 cho- 
lesterol-fed rabbits  received  cortisone  (apparently in  the  same  dosage)  and 
there  occurred  an  accentuation of  hypercholesterolemia and  a  marked  de- 
pression of the phospholipid/cholesterol ratio.  While we  cannot explain the 
different results that occurred in their experiment and in our own, two impor- 
tant differences in experimental method should be mentioned since they may 
account for the discrepancies. Oppenheim and Bruger seem to have adminis- 
tered approximately the same total dose of cortisone per week as we did, but 
it was administered 3 times weekly whereas in the present experiment it was 
divided into 7 doses,  one injection being given daily for 7 days of each week. 
A greater effect may be expected from the latter procedure. Secondly, litter 
mates of the same sex from pedigreed stock were used in our experiment whereas 
Opperhheim and Bruger apparently used ordinary, unselected laboratory rab- 
bits. 
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scarcely  more than inceptive.  However,  two  different methods of assessing 
the severity of the aortic lesions, the one morphological and the other chemical, 
were in substantial agreement and demonstrated that cortisone impeded the 
development of  experimental  cholesterol  atherosclerosis.  While  it  may  be 
unfortunate that more striking differences between the two groups were not 
manifest, nevertheless  the differences between the rabbits that received cho- 
lesterol and their litter mates that received both cortisone and cholesterol were 
so consistent that there can be little doubt that cortisone inhibited the develop- 
ment of atherosclerosis. This result is in agreement with that of Oppenhiem 
and Bruger (16) who reported the inhibition of experimental  atherosclerosis 
in 13 cholesterol-fed rabbits treated with cortisone. It does not agree with that 
of Cook et a~. (15) who reported that cortisone  did not affect the develop- 
ment of experimental  cholesterol atherosclerosis in the rabbit.  However,  be- 
cause their conclusion is based on a study of 3 cholesterol-fed, cortisone-treated 
rabbits it must be viewed with some reservation.  The result is also in disagree- 
ment with that of Stamler, Pick, and Katz (27) who reported an intensification 
of cholesterol-induced atherosclerosls by cortisone in the chick. However, since 
cortisone does not affect avian glycocorticoid metabolism in the same manner 
as that of mammals, the two experiments are not really comparable. The same 
authors (28) have also studied the action of adrenal steroid compound F  in 
cholesterol-fed  chicks  and  reported  an  intensified  hyperlipemia,  hypercho- 
lesterolemia,  and hyperphospholipidemia.  There were no significant  changes 
in aortic atherogenesis. The action of compound  F  in avian species is glyco- 
corticoid and seems analogous to that of cortisone  in mammals. The uncon- 
vincing report of Etheridge and Hoch-Ligeti (13) that there is an enhancement 
of the development of atherosclerosis  in children  treated with cortisone  or 
ACTH is also contrary to the results  reported in the present experiment.  It 
is based on the postmortem visual and microscopic examination of the aortas 
from 54 patients less than 11 years of age of which 26 had been treated with 
cortisone  or ACTH for varying periods  of time. 
The mechanism or mechanisms by which cortisone inhibits the development 
of experimental  cholesterol atherosclerosis are obscure. It is possible to postu- 
late  several  potential  impeding  mechanisms.  The  hypercholesterolemia  in 
the  cortisone-treated,  cholesterol-fed  rabbits  was  significantly  less  than  in 
their cholesterol-fed  litter mates. Their cholesterol/phospholipid  ratios were 
not elevated as much as those of the cholesterol-fed control animals. There may 
have been an alteration in the serum macromolecular lipoproteins. There may 
have been an alteration in the aortic endothelial permeability or in the cellular 
reaction of the aortic intima. 
It is reasonable to assume that a lower level of cholesterol in the serum will, 
of itself, result in a lesser amount of atherosclerosis. It is generally found that 
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serum and  the severity of atherosclerosis  in  cholesterol-fed  rabbits.  On the 
other hand,  it has also been observed in a  variety of studies that the serum 
cholesterol/phospholipid ratio is of importance in the genesis of atherosclerosis 
and  the results  of the present experiment are explicable on  the assumption 
that  the more normal ratio  in the cortisone-treated rabbits  of group 2 pro- 
tected them partially against the development of atherosclerosis.  The effect on 
the cholesterol  levels is analogous to that occurring  in experiments employing 
thyroid, potassium iodide,  and similar  substances (22-25). The effect on the 
phospholipids is analogous to that seen in experiments with alloxan diabetes, 
tween 80, and similar  substances. Apparently cortisone exploits both mecha- 
nisms in the inhibition of experimental atherosderosis. It is of some importance 
to observe that cortisone in the doses employed was only mildly diabetogenic. 
The resulting elevation in blood sugar was generally slight and seldom attained 
levels that were frankly diabetic. On the other hand, its effects on protein me- 
tabolism and on lipid metabolism as judged by the body weights and serum 
lipids were marked. In alloxan diabetes carbohydrate, protein and fat metabo- 
lism are all profoundly altered. 
A third explanation of the partial suppression of the development of athero- 
sclerosis in the rabbits treated with cortisone may be found in the observation 
that  cortisone alters  the serum lipoproteins.  Ultracentrifugal  analyses have 
shown  that  during  the  adminLqtration  of cortisone there  occurs at  first  an 
increase  in  all  types of lipoproteins  (29).  Later,  the  elevated  elements  are 
found to be those in the Ss 80 to 40,000 classes of lipoproteins while there is a 
decrease in the classes of lipoproteins below Sj 80 (30). It has been postulated 
that prolonged treatment with cortisone causes a metabolic block at  the level 
of Sj 80 in the breakdown of the higher SI series to the lower ones. This altera- 
tion in the serum lipoprotein pattern resembles that seen in alloxan diabetes 
in cholesterol-fed  rabbits (31). In each case there is a quantitative increase in 
the higher $f lipoproteins,  an intermediate block, and relatively minor quan- 
tifies of the lower SI series. It has been postulated (32) that the lower lipopro- 
rein classes up to about SI 400, but especially those from about Ss 12 to 50, 
are active atherogenic agents while  the higher series are not.  Unfortunately, 
there  were  no  ultracentrifugal  studies  in  the  present  experiment,  but  it  is 
reasonable to assume the occurrence of variations in the lipoproteins similar 
to those referred to above. The relative lack of the lower Ss atherogenic classes 
of lipoproteins would thus inhibit the development of atherosclerosis. 
The three foregoing  explanations of the manner in which the alterations in 
the serum lipids may act to inhibit the development of atherosclerosis  in cor- 
tisone-treated rabbits should not be regarded as entirely independent of one 
another. Rather, they should be considered,  to some extent at least, as mutually 
interdependent. 
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sclerotic lesions  deserves some  comment.  Many  investigators  consider  that 
the serum lipids  enter and are deposited in the aortic intima by penetrating 
through  the endothelial lining  and into the subendothelial tissue where they 
lead to the formation of atherosclerotic lesions. Variations in the permeability 
of the endothelial layer may therefore be expected to affect the development 
of atherosclerosis.  There is no direct evidence concerning the action of cortisone 
on the endothellum of the aorta and other large vessels, but there are studies 
of its action on the permeability of the capillary endothelium. Cortisone does 
not appear to affect the permeability of the normal capillary endothelium (33). 
However, it greatly reduces the increased capillary permeability observed in 
i~flammation (34) or in starvation (35). It is not known whether aortic endo- 
thellum of normal permeability will permit the passage of atherogenic material 
into the intima, nor is it known whether the endothelium is, in fact, more per- 
meable than  normal  during  the development of atherosclerosis.  However, if 
increased  endothelial  permeability  does play  a  part  in  the  pathogenesis  of 
atherosclerosis,  cortisone might be expected to interfere with the development 
of the lesions. Similarly, it can only be surmised whether cortisone may or may 
not affect the intimal ground substance and thus inhibit the progress of athero- 
sclerosis.  Cortisone is known to have a profound effect on the reactions that 
are commonly associated with inflammation and healing.  Cellular proliferation 
is depressed and cellular infiltration is dimiuished by cortisone. It is theoretically 
possible that the smaller size of the atherosclerotic lesions in the cholesterol-fed 
rabbits treated with cortisone is due, in some part, to an inhibition of the local 
cellular  reactions  that  take  part  in  the  pathogenesis  of  the  atherosclerotic 
lesion. Data pertinent to this problem are not provided by the present experi- 
ment. 
Firstbrook (36, 37) has studied the effect of weight loss or gain on the develop- 
ment of experimental cholesterol  atherosclerosis  in the growing rabbit.  He has 
observed that the average cholesterol content of the blood, the initial  live body 
weight, and the relative final body weight are of about equal statistical  impor- 
tance in determining or estimating the degree  of atherosclerosis  that  will de- 
velop. He finds a high net correlation between relative weight gain during  the 
course of an experiment and  the severity of aortic atherosclerosis.  It is  his 
conclusion  that  caloric  restriction  with  consequent weight loss  or  decreased 
rate of weight gain inhibits the development of atherosclerotic lesions.  How- 
ever, we have carried out experiments (38) to determine whether undernour- 
ished and adequately nourished rabbits fed the same daily doses of cholesterol 
would manifest different degrees of atherosclerosis  at the end of an experiment. 
It was found that no difference  existed in the degrees  of atherosclerosis  that 
were produced by equal daily doses of cholesterol  in different experiments that 
tested the effect of undernutrition  (1)  in young growing  animals  that  failed 
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tion both before and during cholesterol feeding and (3) in fully grown, mature 
rabbits that lost weight during undernutrition. At the same time, undernutri- 
tion was found to promote hypercholesterolemia  in the rabbit fed cholesterol. 
The inhibition of atherosclerosis  observed  in cholesterol-fed  rabbits  treated 
with cortisone cannot be explained by the fact that they lost weight. Indeed, 
the cortisone-treated cholesterol-fed rabbits did not exhibit the degree of hyper- 
cholesterolemia that might be expected either in cholesterol-fed rabbits on an 
ad lib. diet and not otherwise treated or, especially, in undernourished rabbits 
fed cholesterol. 
An experiment  was performed to determine the effect of cortisone  on the 
serum lipids and on the development of experimental cholesterol atherosclerosis 
in the rabbit. Litter mate rabbits of the same sex were employed; both sexes 
were represented in the experiment. The report is based upon four experimental 
groups  comprising  (1)  12  rabbits fed cholesterol and treated with cortisone 
vehicle;  (2)  12  rabbits fed cholesterol  and treated daily with cortisone;  (3) 
11  rabbits treated with cortisone;  and  (4)  7 rabbits  that received  cortisone 
vehicle. 
It was observed  that: (1) There was less aortic atherosclerosis  in the cho- 
lesterol-fed  cortisone-treated rabbits  as  judged by both  morphological  and 
chemical means than in the rabbits fed cholesterol without cortisone treatment. 
(2)  Cortisone  depressed  appreciably the hypercholesterolemia  resulting from 
the feeding of cholesterol to rabbits. (3) Cortisone treatment caused a moderate 
hypercholesterolemia  in  normal  rabbits.  (4)  Cortisone  caused  a  moderate 
increase in serum lipid phosphorus  equal to that produced by cholesterol feed- 
ing alone.  (5)  The combination of cholesterol  feeding and cortisone  did not 
result in a higher phospholipidemia  than either one of these agents alone.  (6) 
Cortisone  caused  a  great increase  in serum-neutral  fat; it was not apparent 
whether cholesterol feeding affected  the neutral fat lipemia  due to cortisone 
treatment alone. (7) The total cholesterol to lipid phosphorus  ratio was about 
normal in  the rabbits  that received  cortisone  only. It  was  doubled in  the 
animals receiving both cholesterol and cortisone,  and it was increased  about 
four times in those that received  only cholesterol. 
The significance of the alterations in the serum lipids induced by cortisone 
is discussed in relation to the inhibition of the development of aortic athero- 
sclerosis that occurred  in the cholesterol-fed rabbits treated with cortisone. 
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